Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or MoreCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorderRecruitingPhase 42026-04-29NCT06622603

7 results · Page 1 of 1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Seoul National University Bundang HospitalSeongnam-siSouth Korea9